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Abstract: 
Insulin-stimulated glucose uptake requires the activation of several signaling pathways to 
mediate the translocation and fusion of GLUT4 vesicles to the plasma membrane. Our previous 
studies demonstrated that GLUT4-mediated glucose uptake is a myosin II-dependent process in 
adipocytes. The experiments described in this report are the first to show a dual role for the 
myosin IIA isoform specifically in regulating insulin-stimulated glucose uptake in adipocytes. 
We demonstrate that inhibition of MLCK but not RhoK results in impaired insulin-stimulated 
glucose uptake. Furthermore, our studies show that insulin specifically stimulates the 
phosphorylation of the RLC associated with the myosin IIA isoform via MLCK. In time course 
experiments, we determined that GLUT4 translocates to the plasma membrane prior to myosin 
IIA recruitment. We further show that recruitment of myosin IIA to the plasma membrane 
requires that myosin IIA be activated via phosphorylation of the RLC by MLCK. Our findings 
also reveal that myosin II is required for proper GLUT-vesicle fusion at the plasma membrane. 
We show that once at the plasma membrane, myosin II is involved in regulating the intrinsic 
activity of GLUT4 after insulin stimulation. Collectively, our results are the first to reveal that 
myosin IIA plays a critical role in mediating insulin-stimulated glucose uptake in 3T3-LI 
adipocytes, via both GLUT4 vesicle fusion at the plasma membrane and GLUT4 activity. 
 
Article: 
INTRODUCTION 
Insulin-stimulated glucose uptake into adipose tissue and skeletal muscle play a critical role in 
glucose homeostasis. Insulin mediates glucose uptake via the insulin responsive glucose 
transporter, (GLUT4). In adipocytes, insulin stimulates (i) the translocation of GLUT4- 
containing vesicles from a perinuclear region to the plasma membrane; (ii) the docking and 
fusion of GLUT4 vesicles at the plasma membrane and (iii) the activation of the intrinsic activity 
of the GLUT4 transporter itself. Several signaling pathways including the phosphoinositol-3 
kinase (PI3 kinase) pathway, the mitogen activated protein kinase (MAPK) pathway and the Cbl 
pathway1–3 are activated by insulin to coordinate GLUT4-mediated glucose uptake by signaling 
GLUT4 vesicle translocation, actin reorganization, and stimulating the intrinsic activity of 
GLUT4 at the plasma membrane. 
 
Previous studies have demonstrated that GLUT4 translocation and membrane fusion require 
reorganization of the cytoskeleton.4–6 Specifically, actin, microtubules and myosin have been 
shown to participate in GLUT4-mediated glucose uptake.4–11 Unlike most cells that have 
extensive arrays of stress fibers, adipocytes have a cortical layer of actin filaments adjacent to the 
cytoplasmic surface of the plasma membrane. In adipocytes, the actin cytoskeleton plays two 
critical roles in vesicle trafficking: i) as “tracks” on which GLUT4- containing vesicles are 
translocated from intracellular pools to the plasma membrane and ii) as a barrier between 
vesicles and the plasma membrane.5, 12 Actin filaments must be reorganized for vesicle 
translocation and to “loosen” the actin barrier at the plasma membrane to facilitate localized 
remodeling of the cell cortex to facilitate vesicle fusion.13–15 Upon cortical actin reorganization, 
GLUT4 vesicles are able to gain access to their proper docking and fusion sites at the plasma 
membrane.14 Reorganization of cortical actin in adipocytes is insulin-dependent and thus is a 
critical component of GLUT4-mediated glucose uptake.5 While previous studies have elucidated 
a role for actin reorganization in GLUT4-mediated glucose uptake, the role of the contractile 
proteins regulating actin reorganization and the subsequent remodeling of the cell cortex has 
only recently been examined. We have demonstrated that the contractile motor protein myosin II 
plays a critical role in GLUT4-mediated glucose uptake. While myosin II facilitates actin 
filament contraction, an activity most commonly associated with muscle contraction, it is also 
involved in nonmuscle cell processes such as cytokinesis, cell locomotion, maintenance of cell 
cortical tension, and cell surface receptor capping.16, 17 Previous studies in mammalian 
nonmuscle cell lines revealed that myosin II is critical in regulating the cytoskeletal 
reorganization required for vesicle fusion with the plasma membrane.18, 19 Thus, myosin II may 
be responsible for the cortical F-actin reorganization required for GLUT4 vesicle fusion in 
adipocytes. 
 
An additional aspect of GLUT4-mediated glucose uptake that may involve the reorganization of 
the cytoskeleton is the regulation of GLUT4 activity. After vesicle fusion, GLUT4 must be 
activated before glucose uptake can occur.20 In muscle cells, studies have shown that p38 
mitogen-activated protein kinase (p38 MAPK) is necessary for complete GLUT4 activity20–22 
whereas in adipocytes, p44/p42 mitogen-activated protein kinase (p44/p42 MAPK) was found to 
increase GLUT4 activity.23 The precise interaction between p38 MAPK or p44/p42 MAPK and 
GLUT4 is still unknown, but studies have suggested that the increased GLUT4 activity is due to 
either the interaction of an activator ligand with GLUT4 or the removal of an inhibitory ligand 
from GLUT4.21 It is possible that myosin II-mediated actin reorganization plays a role in the up-
regulation of GLUT4 activity by allowing p38 MAPK, p44/p42 MAPK or some other protein 
access to membrane-bound GLUT4. 
 
Myosin II is a hexameric protein consisting of two heavy chains, two essential light chains 
(ELCs) and two regulatory light chains (RLCs).16 The heavy chains are structurally oriented to 
form a globular head domain that possesses binding sites for ATP and actin. Myosin II motor 
activity and parallel filament assembly are regulated by the phosphorylation of residues localized 
on the RLCs.8, 16 Three kinases have thus far been identified that phosphorylate the RLC of 
myosin II: the Ca2+ / calmodulin dependent myosin light chain kinase (MLCK), Rho kinase 
(RHOK) and p21 activated kinase.8, 16 Phosphorylation of the RLC via MLCK initiates the 
binding of myosin II to filamentous actin.24–26 Interestingly, the RLC of myosin II is the only 
known substrate for MLCK.16 Several heavy chain isoforms of myosin II have been identified. 
Most vertebrate species express varying levels of the myosin II isoforms, myosin IIA and IIB. 
The expression and localization of each isoform is cell type-dependant.16 In osteoclasts myosin 
IIA is localized at dynamic regions of cytoskeletal reorganization whereas myosin IIB remains 
somewhat constant throughout different osteoclast activation cycles.27 Since two myosin 
isoforms have been identified in 3T3-L1 adipocytes it is possible that the two have distinct 
intracellular localization patterns during the dynamic process of insulin stimulated glucose 
uptake.10 It is also of interest to determine whether the myosin II isoforms are recruited to 
facilitate glucose uptake and which of the isoforms is being activated during insulin stimulated 
glucose uptake. While previous studies have shown specific localization patterns of the myosin 
IIA and IIB isoforms in various cell types,16, 27–31 the specific functions of each isoform are not 
yet clear due to their diverse distribution and dynamic localization. 
 
Our previous studies were the first to demonstrate a fundamental role for myosin II in regulating 
the dynamic cellular processes driving GLUT4-mediated glucose uptake in adipocytes, but not 
GLUT4 translocation to the plasma membrane.10 Our study also showed that adipocytes express 
both myosin IIA and IIB isoforms, and that in unstimulated adipocytes myosin IIA was localized 
primarily in the perinuclear region of the cell while myosin IIB was highly enriched at the cell 
cortex. Upon insulin stimulation myosin IIA relocalized to the cell cortex while the localization 
of myosin IIB was unchanged. These findings suggest that the two isoforms have different roles 
in adipocytes. Collectively, our results demonstrated that myosin II plays a critical role in 
mediating insulin-stimulated glucose uptake in 3T3-LI adipocytes, possibly via a mechanism that 
facilitates GLUT4 vesicle fusion at the plasma membrane. In the present study we examined 
myosin II isoform activation and the role the isoforms play in GLUT4-mediated glucose uptake. 
Our results reveal a novel role for myosin IIA in regulating GLUT4 vesicle fusion and GLUT4 
activity. Thus our studies are the first to demonstrate a dual role for the myosin IIA isoform in 
regulating insulin-stimulated glucose uptake in adipocytes. 
 
MATERIALS AND METHODS 
Materials 
Tissue culture reagents were obtained from Gibco (Grand Island, NY). Insulin was purchased 
from Roche Diagnostics Corporation (Indianapolis, IN). Dexamethasone, 3-isobytyl-1-
methylxanthine, ML-7 and myosin IIA antibody were from Sigma (St. Louis, MO). Blebbistatin 
was purchased from Calbiochem (San Diego, CA). Myosin light chain (phospho S20) antibody 
was purchased from Abcam (Cambridge, MA). GLUT4 antibodies (C-20 and N-20) were from 
Santa Cruz Biotechnology (Santa Cruz, CA). The myosin IIB antibody and Texas Red Phalloidin 
were obtained from Covance (Berkeley, CA). Alexa Fluor® 594 donkey anti-goat IgG and goat 
anti-rabbit IgG were from Molecular Probes, Inc. (Eugene, OR). The enhanced 
chemiluminescence (ECL) detection kit and horseradish peroxidase conjugated secondary 
antibodies were from Amersham Bioscience (Piscataway, NJ). 
 
Glucose uptake assay 
3T3-L1 preadipocytes were induced to differentiate as described previously.32 Glucose uptake 
assays were performed on fully differentiated 3T3-L1 adipocytes. Adipocytes were serum-
starved for 4 h in the presence of 0.1% DMSO (Basal) or inhibitor as indicated. Adipocytes were 
then washed twice with 37 °C Krebs Ringer Phosphate (KRP) buffer (pH 7.4) containing 128 
mM NaCl, 4.7 mM KCl, 1.65 mM CaCl2, 2.5 mM MgSO4, 5 mM Na2HPO4 and then placed in 
KRP buffer containing vehicle, 10 µM ML-7, 10 µM ML-9 or 10 µM Y-27632 as indicated. 
Adipocytes were either untreated (basal) or treated with insulin (100 nM) for 10 min, followed 
by the addition of [1-14C]-2-deoxy-D-glucose (0.1µCi/well) (NEN) and 5 mM glucose for an 
additional 10 min at 37 °C. Cells were then washed three times with phosphate buffered saline 
(PBS) and solubilized in 0.5 M NaOH and 0.1% SDS. Samples were assayed for 14C-2-deoxy-D-
glucose uptake as disintegrations per min per mg protein. Data are expressed as means ± SEM. 
 
Immunoblot analysis 
3T3-L1 adipocytes were lysed in a buffer containing 25 mM HEPES pH 7.4, 1% Nonidet P-40, 
100 mM NaCl, 2% glycerol, 5 mM NaF, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaPPi, 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 10 mg/ml aprotinin, 5 mg/ml leupeptin, and 5 mg/ml 
pepstatin.5 Lysates were incubated at 4°C for 20 min and then centrifuged at 6,000 × g for 20 
min at 4°C. The supernatants were incubated for 5 minutes at 95°C in Laemmli sample buffer,33 
and then subjected to SDS-PAGE. Proteins were transferred to Immobilon-P membranes 
(Millipore), and analyzed by immunoblotting as previously described.32 Protein bands were 
quantified by densitometry using ImageQuant (version 5.2 for Windows) software. 
 
Immunoprecipitation 
Antibodies (3 µg/ml) were added to whole cell lysates (1 mg) and incubated overnight at 4 C. 
Agarose beads (protein A/G PLUS–agarose beads) were added to the immunoprecipitates and 
agitated for 1 h at 4 C. Immunoprecipitates were recovered by centrifugation at 2500 × g and 
washed three times with ice cold lysis buffer. Immunoprecipitated proteins were dissolved in 5 × 
Laemmli buffer, heated for 5 min at 95 C, and then subjected to SDS-PAGE and immunoblot 
analysis. 
 
Immunofluorescence 
Differentiated adipocytes grown on coverslips were serum starved for 4 h and treated according 
to the glucose uptake protocol (omitting 14C-2-DOG) for the time indicated. Cells were then 
fixed with 2% buffered paraformaldehyde, permeablized in 0.25% triton X-100 for 5 min at 4°C, 
and incubated with anti-GLUT4 antibody or anti-myosin IIA antibody. The slides were then 
incubated with the appropriate secondary labeled antibodies (Molecular Probes, Eugene, OR). 
Slides were viewed using an Olympus IX81 Motorized Inverted Confocal Microscope and 
FLUOVIEW FV5OO software. The relative intensity of immunofluroescence was quantified 
using Image-Pro Plus software (Silver Spring, MD). 
 
Determination of cell surface GLUT4 
Fully differentiated 3T3-L1 adipocytes were serum starved in the presence or absence of 
inhibitor as indicated. Cells were then either treated with 0.1% DMSO (Basal), 100 nM insulin 
(Insulin) or with 100 nM insulin and either 100 µM blebbistatin or 10 µM ML-7 for 30 min. 
Adipocytes were fixed with 3.7% formaldehyde, incubated for an hour with a GLUT4 antibody 
(1:100) targeted against an epitope in the extracellular domain and then incubated with anti-goat 
Alexaflour 594 for 45 minutes. Slides and viewed using an Olympus IX81 Motorized Inverted 
Confocal Microscope and FLUOVIEW FV500 software. 
 
Analysis of embedded GLUT4 
Adipocytes were incubated at 37°C in KRP buffer and then treated with 0.1% DMSO (Basal) or 
stimulated with 100 nM insulin alone or 100 nM insulin in the presence of either 100 µM 
blebbistatin or 10 µM ML-7. Immediately following, [14C]2-deoxy-D-glucose (0.1 µCi/well) and 
5 mM glucose were added to each well. Cells were then washed three times with PBS at 4°C and 
lysed with 1 mL of a 0.5M NaOH and 0.1% SDS solution. Samples were assayed for 14C-2-
deoxy-D-glucose uptake as described previously.32 
 
Statistical analysis 
Data are expressed as means ± SEM. The significance of differences between means, set at P < 
0.05, was assessed by Student’s t-test (Microsoft Excel). 
 
RESULTS 
Myosin light chain kinase activity is required for insulin-stimulated glucose uptake 
Our previous studies revealed that myosin II plays a necessary role in GLUT4-mediated glucose 
uptake.10 Myosin II activity is primarily regulated by the phosphorylation status of the RLC 
subunit of myosin II. In order to elucidate the signaling mechanism by which insulin regulates 
myosin II activity in GLUT4-mediated glucose uptake, we investigated two upstream regulators 
of myosin II activity, myosin light chain kinase, (MLCK) and Rho kinase, (RhoK). Both of these 
kinases are known to phosphorylate the RLC and consequently stimulate myosin II activity 
(reviewed in16). Fully differentiated adipocytes were serum starved for 4 h in the presence or 
absence of two MLCK inhibitors, ML-7 or ML-9, or the RhoK inhibitor, Y27632 and then 
glucose uptake assays were performed in the presence or absence of the appropriate inhibitors 
and 14C 2-deoxy-D-glucose. As shown previously, insulin stimulated a dramatic increase in 
glucose uptake over basal levels (Fig. 1). Insulin typically stimulated approximately a five-fold 
increase in glucose uptake over basal levels. Both MLCK inhibitors, ML-7 and ML-9 impaired 
insulin-stimulated glucose uptake by approximately 50% compared with insulin alone. In 
contrast, treatment of adipocytes with the RhoK inhibitor, Y27632 had no effect on insulin-
stimulated glucose uptake. These finding not only support previous studies that myosin II 
activity is required for insulin-stimulated glucose uptake, but also indicate that insulin stimulates 
myosin II activity via MLCK.8, 10 
 
Figure 1: Inhibition of MLCK impairs insulin-stimulated glucose uptake in 3T3-L1 adipocytes 
 
3T3-L1 adipocytes were serum starved in the presence of 10 µM ML-7, 10 µM ML-9, 10 µM Y-27632 or vehicle (0.1% DMSO). Cells were then 
either unstimulated (Basal) or stimulated with 100 nM insulin in the presence of 10 µM ML-7, 10 µM ML-9, 10 µM Y-27632 or vehicle (0.1% 
DMSO) as indicated and assayed for 14C 2-deoxy-D-glucose uptake, which was calculated as disintegrations per mg protein and expressed as 
percent of the vehicle control. Results are the means ± SEM of three independent experiments. 
 
 
 
ML-7 blocks the insulin-stimulated phosphorylation of the RLC associated with myosin IIA 
In order to determine the mechanism by which the insulin signaling pathway regulates myosin II 
activity, we examined the phosphorylation status of the RLC of myosin II prior to and after 
insulin stimulation in the presence and absence of the MLKC inhibitor ML-7. Phosphorylation of 
the RLC on serine 19 by MLCK regulates myosin II activity. Using a RLC-phospho serine 19 
specific antibody we observed that in the basal state only a low level of phospho-RLC (p-RLC) 
was detected in whole cell lysates (Fig. 2A). Upon insulin stimulation, there was a dramatic 
increase in the level of phospho-RLC (Fig. 2A). In order to determine whether the insulin-
induced phosphorylation of the RLC was due to MLCK activity, we inhibited MLCK activity 
with ML-7. Adipocytes treated with insulin in the presence of ML-7 had levels of p-RLC similar 
to unstimulated adipocytes (Fig. 2A). Since our previous studies showed that inhibition of the 
myosin II-actin interaction impaired insulin-stimulated glucose uptake,10 we wanted to determine 
whether the phosphorylation status of the RLC was dependent on a myosin II-actin association. 
In order to inhibit the myosin II-actin interaction, we used the myosin II specific inhibitor 
blebbistatin. Blebbistatin impairs the physical interaction between myosin II and actin.34–38 
Blebbistatin treatment did not affect the phosphorylation status of the RLC. Our results further 
showed that the differences in the levels of phosphorylated RLC were due to the degree of 
phosphorylation and not the levels of total RLC since the absolute levels of RLC were 
unchanged under all conditions (Fig. 2A). The relative levels of p-RLC to RLC were quantified 
by densitometry (Fig. 2B). 
 
Figure 2: Insulin stimulates phosphorylation of the regulatory light chain associated with myosin 
IIA 
   
 
 
3T3-L1 adipocytes were serum starved for 4 hours in the presence of vehicle (0.1% DMSO), 100 µM blebbistatin or 10 µM ML-7. Cells were 
then either left untreated (basal) or stimulated with 100 nM insulin. (A) Whole cell lysates were prepared, subjected to 10% SDS-PAGE and then 
immunoblotted using antibodies to either a phosphorylated myosin II RLC (p-RLC) or myosin II RLC (RLC). (B) Immunoblots were quantified 
by densitometry. Values are expressed as a fold of the basal value. Results are the means ± SEM of three independent experiments. Whole cell 
lysates from untreated and insulin-stimulated adipocytes were subjected to the immunoprecipitation (IP) protocol using either a (C) myosin IIA or 
(D) myosin IIB antibody. Immunoprecipitates were then subjected to 10% SDS-PAGE and immunoblotted (IB) with antibodies directed against 
myosin IIA, myosin IIB, RLC or p-RLC. (E) Whole cell lysates were prepared from untreated adipocytes and adipocytes stimulated with 100 nM 
insulin in the presence or absence of 10 µM ML-7. Lysates were then subjected to the immunoprecipitation protocol using a myosin IIA 
antibody. Immunoprecipitates were analyzed by 10% SDS-PAGE and immunoblotted with a p-RLC antibody. Results are representative of three 
independent experiments. 
 
Our previous studies revealed that 3T3-L1 adipocytes express both myosin IIA and IIB.10 In 
order to determine whether one or both isoforms are activated by insulin signaling we 
immunoprecipitated either myosin IIA (Fig. 2C) or IIB (Fig. 2D) using myosin II-isoform 
specific antibodies from unstimulated and insulin-stimulated 3T3-L1 adipocytes. As shown in 
Fig 2C and 2D, insulin induced a dramatic increase in the levels of phosphorylated RLC that 
immunoprecipitated with the myosin IIA antibody when compared to levels in unstimulated 
cells. In contrast, there was no alteration in the phosphorylation status of the RLC associated 
with myosin IIB (Fig. 2D). In order to ensure that the differences detected in the levels of 
phosphorylated RLC were due to phosphorylation of the RLC and not to differences in the total 
levels of the RLC, we also determined the levels of RLC by immunoblot analysis. As seen in Fig 
2C and 2D there were no differences in the levels of total RLC. We also performed immunoblot 
analysis for the specific myosin isoforms to ensure the specificity of our immunoprecipitation 
assays (Fig. 2C and D). 
 
Next we were interested in determining if MLCK mediated the insulin-stimulated 
phosphorylation of the RLC associated with myosin IIA. 3T3-L1 adipocytes were stimulated 
with insulin in the presence or absence of 10 µM ML-7. Myosin IIA was immunoprecipitated 
and then immunoprecipitates were subjected to immunoblot analysis with a phospho-RLC 
antibody (Fig. 2E). Inhibition of MLCK activity via ML-7 treatment during insulin stimulation 
blocked phosphorylation of the RLC associated with myosin IIA. Taken together these results 
indicate that only the myosin IIA isoform is regulated by insulin and that insulin activates 
myosin IIA activity via phosphorylation of the RLC by MLCK. 
 
Myosin IIA and GLUT4 vesicles interact at the plasma membrane 
Upon insulin stimulation, GLUT4 translocates from a perinuclear region to the plasma 
membrane in adipocytes. Similarly, our previous studies have shown that myosin IIA is recruited 
from intracellular pools to the plasma membrane upon insulin stimulation.10 We have also shown 
that inhibition of myosin II impairs insulin-stimulated glucose uptake but not GLUT4 
translocation to the plasma membrane.10 Collectively, these studies suggest that GLUT4 is either 
unable to fuse to the plasma membrane or is not embedded properly without myosin II activity. 
If myosin II is involved in the cytoskeletal reorganization required for GLUT4 fusion with the 
plasma membrane then GLUT4 and myosin IIA may colocalize at the plasma membrane upon 
insulin stimulation. In order to investigate this question we examined the localization patterns of 
GLUT4 and myosin IIA by confocal microscopy in unstimulated (Basal) and insulin-stimulated 
3T3-L1 adipocytes. In the basal state, both GLUT4 and myosin IIA colocalized primarily to the 
perinuclear region (Fig. 3A, panels A–C). Upon insulin stimulation, both GLUT4 and myosin 
IIA translocate to the plasma membrane (Fig. 3A, panels D and E). We observed that myosin IIA 
and GLUT4 colocalized in both the perinuclear region prior to insulin treatment and at the 
plasma membrane after insulin stimulation (Fig. 3A). 
 
 
 
Figure 3: Myosin IIA and GLUT4 associate in an insulin-dependent manner 
 
 
(A) 3T3-L1 adipocytes grown on coverslips were serum starved for 4 hours and then either left untreated (Basal) or stimulated with 100 nM 
insulin. GLUT4 and Myosin IIA localization was examined by confocal microscopy as described in Materials and Methods. Whole cell lysates 
from untreated adipocytes and adipocytes stimulated with 100 nM insulin in the presence or absence of 100 µM blebbistatin, or 10µM ML-7 were 
subjected to the immunoprecipitation protocol (IP) using a either a (B) myosin IIA antibody or a (C) GLUT4 antibody. Immunoprecipitates were 
then subjected to 10% SDS-PAGE and immunoblotted (IB) with either a myosin IIA antibody or a GLUT4 antibody. The results are 
representative of three independent experiments. 
 
Next we wanted to determine whether there was an association between myosin IIA and GLUT4 
and whether this association was insulin-dependent. Whole cell lysates from unstimulated 
(Basal) and insulin-stimulated 3T3-L1 adipocytes were subjected to an immunoprecipitation 
protocol using either a myosin IIA or a GLUT4 antibody. As shown in Fig 3B and 3C there was 
little association between myosin IIA and GLUT4 in the basal state. Upon insulin stimulation, 
there was a significant increase in the association between GLUT4 and myosin IIA. These 
findings indicate that while GLUT4 and myosin IIA colocalized at the perinuclear region in the 
basal state they did not interact. In contrast, GLUT4 and myosin IIA colocalized at the plasma 
membrane and co-immunoprecipitated after insulin stimulation. These findings suggest that 
myosin IIA may facilitate the fusion and/or functioning of GLUT4 at the plasma membrane in an 
insulin-dependent manner. 
 
Myosin IIA is recruited to the plasma membrane after GLUT4 translocation 
Since GLUT4 and myosin IIA colocalize at both the perinuclear region prior to insulin 
stimulation and at the plasma membrane after insulin treatment, we wanted to investigate 
whether myosin IIA is recruited prior to, with, or after GLUT4 vesicles to the plasma membrane. 
Our previous studies demonstrated that GLUT4 can translocate to the plasma membrane 
independently of myosin IIA.10 We stimulated 3T3-L1 adipocytes with insulin for various time 
points and then used confocal microscopy to determine the localization of myosin IIA and 
GLUT4. As shown in Fig 4, in the unstimulated state (Basal) myosin IIA and GLUT4 are both 
colocalized to the perinuclear region. GLUT4 vesicles are detected at the plasma membrane after 
four minutes of insulin stimulation (Fig. 4). The level of GLUT4 at the plasma membrane 
increased throughout the 10 min insulin treatment. In contrast, myosin IIA is only detected at the 
plasma membrane 6 min after insulin stimulation and levels continue to increase up to 10 min 
after insulin stimulation (Fig. 4). We further show that GLUT4 and myosin IIA colocalize at the 
plasma membrane as early as 6 min after insulin stimulation and that GLUT4 precedes myosin 
IIA translocation to the plasma membrane (Fig. 4). 
 
Figure 4: Insulin stimulates GLUT4 translocation prior to myosin IIA recruitment to the plasma 
membrane 
 
3T3-L1 adipocytes grown on coverslips were serum starved for 4 hours and then either left untreated (Basal) or stimulated with 100 nM insulin. 
GLUT4 and Myosin IIA localization was examined by confocal microscopy (as described in Materials and methods) prior to and at various time 
points after insulin stimulation, as indicated. The results are representative images from three independent experiments. 
 
MLCK activation of myosin IIA is required for its recruitment to the plasma membrane 
Our previous studies demonstrated that GLUT4 translocation is independent of myosin IIA 
recruitment but GLUT4-mediated glucose uptake is a myosin II-dependent process.10 Since 
insulin signaling stimulates both the translocation of myosin IIA to the plasma membrane (Fig. 
4) and the activation of myosin IIA via MLCK phosphorylation of the RLC associated with 
myosin IIA (Fig. 2E) we wanted to determine whether recruitment of myosin IIA to the plasma 
membrane required its activation via MLCK. 3T3-LI adipocytes were treated with insulin in the 
presence of 10 µM ML-7 for various times and the localization of GLUT4 and myosin IIA was 
examined by confocal microscopy. As shown in Fig. 5 myosin IIA was not recruited to the 
plasma membrane even after 10 minutes of insulin stimulation in the presence of ML-7 (Fig. 5). 
In contrast, GLUT4 vesicles translocated to the plasma membrane in the presence of ML-7 (Fig. 
5, also see merged image). These findings indicate that myosin IIA activation via MLCK is 
required for its recruitment to the plasma membrane upon insulin stimulation of adipocytes. 
 
 
 
Figure 5: Myosin IIA activity is required for its recruitment to the plasma membrane 
 
3T3-L1 adipocytes grown on coverslips were serum starved for 4 hours and then stimulated with 100 nM insulin and 10 µM ML-7. GLUT4 and 
Myosin IIA localization was examined by confocal microscopy (as described in Materials and methods) at various time points after insulin 
stimulation, as indicated. The results are representative images from three independent experiments. 
 
Myosin II is required for GLUT4 vesicle fusion at the plasma membrane 
The translocation, docking and fusion of GLUT4 vesicles is required for insulin-stimulated 
glucose uptake in adipocytes. Our previous studies have found that myosin II is not required for 
GLUT4 vesicle translocation, but is necessary for proper GLUT4-mediated glucose uptake.10 
What is not known is if myosin II is required for GLUT4 vesicle fusion with the plasma 
membrane. To determine whether myosin II is required for GLUT4 vesicle fusion, 3T3-L1 
adipocytes were serum starved for 4 hours in the presence of either 0.1% DMSO, 100 µM 
blebbistatin, or 10 µM ML-7 and then left untreated (Basal) or stimulated with insulin in the 
presence or absence of 100 µM blebbstatin, or 10 µM ML-7. Cells were fixed, incubated with a 
GLUT4 antibody directed against an epitope in an exofacial domain of GLUT4 and then plasma 
bound GLUT4 was visualized by confocal microscopy. As previously shown, insulin-stimulated 
a dramatic increase in plasma membrane bound GLUT4 compared to unstimulated adipocytes 
(Fig. 6, panel A and B). To determine whether a myosin II-cortical actin interaction was 
necessary for the GLUT4 vesicle fusion at the plasma membrane, adipocytes were treated with 
insulin and blebbistatin. Blebbistatin treatment significantly decreased the levels of plasma 
membrane bound GLUT4 compared to insulin-stimulated cells (Fig. 6, panel B and C). In order 
to determine whether myosin II activity was required for proper GLUT4 insertion into the 
plasma membrane, cells were treated with the MLCK inhibitor ML-7. Adipocytes treated with 
insulin and ML-7 showed a substantial decrease in the level of properly fused GLUT4 vesicles 
compared to adipocytes stimulated with insulin alone (Fig. 6, panel B and D). Differential 
interference contrast (DIC) images of each treatment (Fig. 6, panels E–H) were taken in addition 
to the confocal images. Thus these studies demonstrate that myosin IIA recruitment, activation 
and association with actin are necessary for proper GLUT4 insertion in the plasma membrane. 
 
 
 
Figure 6: Inhibition of myosin II activity inhibits GLUT4 vesicle fusion with the plasma 
membrane 
 
3T3-L1 adipocytes grown on coverslips were serum starved for 4 hours in the absence or presence of 100 µM blebbistatin or 10 µM ML-7 as 
indicated. Cells were then left untreated (basal) or stimulated with 100 nM insulin in the absence or presence of inhibitors and then treated 
according to the immunofluorescence protocol (as described in Materials and Methods). Fused GLUT4 vesicles were visualized using a GLUT4-
specific antibody targeting an epitope in an exofacial domain. GLUT4 localization in adipocytes was examined in (A) unstimulated (Basal), (B) 
stimulated with 100 nM insulin (Insulin) or in the presence of 100 nM insulin and (C) 100 µM blebbistatin or (D) 10 µM ML-7. Differential 
Interference Contrast (DIC) images of each treatment were taken as well (E–H). The results are representative images from three independent 
experiments. 
 
Myosin II facilitates GLUT4 intrinsic activity 
Previous studies have found that myosin II is required for GLUT4-mediated glucose uptake.8, 10 
This could reflect a requirement of myosin II for GLUT4 vesicle fusion and/or GLUT4 activity. 
Our findings here demonstrate that myosin IIA is required for proper GLUT4 insertion. Next we 
wanted to determine whether myosin II also affects GLUT4 intrinsic activity, so we examined 
the activity of plasma membrane embedded GLUT4 in the absence of GLUT4 translocation by 
performing short-term glucose uptake assays. In the basal state most but not all of the plasma 
membrane bound GLUT4 is internalized, resulting in a very low level of GLUT4 at the plasma 
membrane. Like GLUT4, myosin IIA is also present at low levels at the plasma membrane in the 
basal state (Fig. 3A, panels A–C). Thus using a short-term glucose uptake assay allowed us to 
examine the role of myosin IIA on the activity of embedded GLUT4. 3T3-L1 adipocytes were 
serum starved for 4 hours to internalize most, but not all the membrane bound GLUT4. After 
serum starvation, adipocytes were subjected to short-term glucose uptake assays using [14C]2-
deoxy-D-glucose. Previous studies have shown that maximum GLUT4 translocation to the 
plasma membrane occurs between 10–14 minutes.12, 39 Thus, the short time period should only 
examine glucose uptake from embedded GLUT4. Insulin-stimulated adipocytes showed a two-
fold increase in glucose uptake compared to unstimulated (Basal) adipocytes (Fig. 7). To 
determine whether myosin II association with actin was necessary for GLUT4 activity, 
adipocytes were stimulated with 100 nM insulin in the presence of 100 µM blebbistatin. 
Blebbistatin treated adipocytes showed approximately a 70% inhibition of insulin-stimulated 
glucose uptake (Fig. 7). Next we wanted to determine whether insulin signaling via MLCK and 
thus myosin II activity was required for GLUT4 activity. Serum starved adipocytes were treated 
with 100 nM insulin and 10 µM ML-7 and then subjected to the short-term glucose uptake assay. 
ML-7 treated adipocytes showed approximately a 40% inhibition of insulin-stimulated glucose 
uptake compared to insulin-stimulated adipocytes (Fig. 7). These results show for the first time 
that myosin II activity via MLCK is required for GLUT4 intrinsic activity and that myosin II-
interaction with cortical actin is required for GLUT4 activity. 
 
Figure 7: Myosin II regulates the intrinsic activity of GLUT4 during insulin-stimulated glucose 
uptake in 3T3-L1 adipocytes 
 
Adipocytes were serum starved for 4 hours and stimulated with insulin for 2 min and assayed for embedded GLUT4 (as described in Materials 
and Methods) in the presence of 0.1% DMSO (Basal), 100 nM insulin, 100 nM insulin and either 10 µM blebbistatin or 10 µM ML-7. Adipocytes 
were assayed for incorporated [14C]2-deoxy-D-glucose which was calculated as disintegrations per mg protein. The data are expressed as a 
percent of the vehicle control. Results are means ± SEM of three independent experiments. 
 
DISCUSSION 
Recent studies have identified a critical role for myosin II in GLUT4-mediated glucose uptake in 
adipocytes.8, 10 Since 3T3-L1 adipocytes express both myosin IIA and IIB isoforms, it is 
important to define the role of each of the isoforms during insulin-stimulated glucose uptake. 
While a role for myosin II in actin contraction has been well characterized in muscle cells, the 
role for myosin II in nonmuscle cells is less well defined. Several studies have demonstrated a 
role for the members of the myosin family in a nonmuscle cell context.15, 18, 25, 26, 28 Myosin 
family members have been shown to traffic vesicles along filamentous actin tracks, and to 
mediate localized actin reorganization during cell migration and cytokinesis.16, 17, 40 Insight into 
the role for myosin II in nonmuscle cells comes from chromaffin cells where myosin II mediates 
contraction of the actin cytoskeleton which leads to localized remodeling at the cell cortex that 
may be required for vesicle fusion with the plasma membrane.18 
 
Our study is the first to show that insulin differentially regulates the activity of the myosin II 
isoforms in adipocytes. We show that insulin specifically signals phosphorylation of the RLC 
associated with the myosin IIA isoform while the RLC associated with the myosin IIB isoform is 
not affected by insulin. These studies may provide insight into the different roles of the myosin II 
isoforms in adipocytes. Furthermore, we show that inhibition of MLCK using two different 
inhibitors (ML-9 and ML-7) but not a Rho kinase inhibitor impaired insulin-stimulated glucose 
uptake and that ML-7 treatment prevented the insulin mediated phosphorylation of myosin IIA. 
These findings demonstrate that insulin regulates the activity of the myosin IIA isoform 
specifically via MLCK to promote glucose uptake in adipocytes. These results are similar to 
those reported in a recent study showing that repulsive guidance molecule regulated the myosin 
IIA isoform specifically to inhibit neurite outgrowth.41 Additionally, our studies demonstrated 
that phosphorylation of the RLC is required for the translocation of myosin IIA from the 
perinuclear region to the plasma membrane. Similarly histamine has been shown to induce the 
redistribution of only the myosin IIA isoform to lamellipodial extensions at the cell periphery of 
gastric parietal cells.42 Our previous studies demonstrated that in the basal state myosin IIA is 
present in the perinuclear region while myosin IIB is localized at the cell cortex.10 In other cell 
types where both isoforms are expressed, distinct localization patterns have been identified 
where only one isoform may occupy a specific intracellular space at a given time.27, 31 While in 
MDA-MB-231 breast cancer cells, increased levels of RLC phosphorylation coincided with 
recruitment of both myosin IIA and IIB to the lamellar margin during active spreading.43 The 
novel findings in this study demonstrate that insulin differentially regulates the myosin II 
isoforms and provides further insight into the differing role of the myosin isoforms in nonmuscle 
cells. These studies also identify another specific downstream target (myosin IIA) of insulin 
signaling and also another insulin-stimulated pathway required for GLUT4-mediated glucose 
uptake in adipocytes. 
 
Furthermore, our studies demonstrate that while myosin IIA and GLUT4 colocalize at both the 
perinuclear region (prior to insulin stimulation) as well as at the plasma membrane (after insulin 
stimulation) there is only a physical association between myosin II and GLUT4- containing 
vesicles at the plasma membrane after insulin stimulation. We also show that insulin stimulates 
GLUT4 translocation to the plasma membrane prior to myosin IIA recruitment. Furthermore we 
demonstrate that myosin IIA must be phosphorylated on its RLC by MLCK to translocate to the 
plasma membrane. Inhibition of myosin IIA recruitment to the plasma membrane does not 
inhibit GLUT4 translocation but does result in impaired glucose uptake. These studies 
demonstrate that insulin activation of myosin IIA is required for its recruitment to the plasma 
membrane and GLUT4-mediated glucose uptake. Myosin IIA may be involved in the actin 
reorganization required at the plasma membrane for GLUT4 vesicle membrane fusion.4– 6, 44 This 
would explain the recruitment of active myosin IIA to sites where GLUT4 is present to aide in 
the coordinated insertion of GLUT4 into the plasma membrane. 
 
The cortical actin cytoskeleton acts as a barrier to either endocytosis or exocytosis at the plasma 
membrane. When myosin II activity is inhibited, insulin stimulated glucose uptake is impaired 
yet GLUT4 vesicles still translocated to the plasma membrane. This suggests that myosin II is 
involved in some downstream event in GLUT4 mediated glucose uptake such as GLUT4 vesicle 
fusion with the plasma membrane. Our studies demonstrate that inhibition of myosin activity 
with either blebbistatin or ML-7 significantly reduced the level of GLUT4 embedded in the 
plasma membrane after insulin stimulation. These findings suggest that although GLUT4 
translocated to the plasma membrane it is unable to embed into the membrane without active 
myosin IIA at the plasma membrane. Additionally we show that myosin must interact with actin 
to allow GLUT4 to embed into the membrane. Previous studies have shown that contraction of 
the actin cytoskeleton in rat chromaffin cells and human MRC-5 fibroblasts resulted in localized 
remodeling at the cellular cortex.14, 31 The dynamic process of actin remodeling may be 
responsible for the docking and fusion of GLUT4 vesicles with the plasma membrane. 
 
In the present study we not only demonstrate that myosin II is required for GLUT4 vesicle fusion 
with the plasma membrane but that it is also involved in GLUT4 activity. In the basal state, 
adipocytes are serum starved to allow GLUT4 internalization. We found that like GLUT4, 
myosin IIA is also present at low levels at the plasma membrane in the basal state. Inhibition of 
myosin II activity or association with actin impaired glucose uptake from embedded GLUT4. 
Previous studies have shown that after vesicle fusion, GLUT4 has to be activated before glucose 
uptake can occur.20 While both p38 MAPK in muscle cells and p44/p42 MAPK in adipocytes 
were found to increase GLUT4 activity, the precise role of these factors is not well understood.1, 
20–22 It has been suggested that GLUT4 activity is regulated by its interaction with either an 
activator ligand or the removal of an inhibitory ligand.21 It is tempting to speculate that myosin 
II-mediated actin reorganization is involved in increasing GLUT4 activity by allowing p38 
MAPK, p44/p42 MAPK or some other protein access to membrane-bound GLUT4. 
 
In summary, our studies show that insulin specifically stimulates the myosin IIA isoform via 
MLCK. We also show that inhibition of myosin IIA activity prevented its translocation to the 
plasma membrane and subsequently impaired GLUT4-mediated glucose uptake by preventing 
GLUT4 from embedding into the plasma membrane. Our results also demonstrate that myosin 
IIA activity is required for the intrinsic activity of embedded GLUT4. Collectively, our studies 
demonstrate that insulin stimulates myosin IIA activity and promotes the embedding of GLUT4 
into the plasma membrane and the activation of GLUT4. Our findings further delineate the role 
of cytoskeletal factors involved in insulin-stimulated glucose uptake and thus provide further 
insight on the basis of impaired insulin sensitivity. 
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